← Back to news

Markets

UK retailers warn Chancellor ahead of autumn budget

Y

New packaging recyclability rules come into force in Germany

Y

Table-top vacuum packaging machines for small businesses

Y

Amicus Therapeutics, Inc. (FOLD) Expands Pipeline With Rare Kidney Disease Drug

Y

Collegium Pharmaceutical, Inc. (COLL) Highlights Real-World Evidence at PAINWeek 2025

Y

Trump says Fed rate cuts will make a solid US economy even better. Is he right?

Y

Ardent Health, Inc. (ARDT) Expands Footprint with 18 New Urgent Care Clinics in 2025

Y

Alexandria: Why This Life Science REIT Looks Too Cheap To Ignore

S

Integra LifeSciences Holdings Corporation (IART) Focuses on Supply Chain Recovery and Growth Strategy

Y

Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition

Y

CorMedix Inc. (CRMD) Acquires Melinta Therapeutics to Expand Hospital-Focused Portfolio

Y

Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal

Y

Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women’s Health Portfolio

Y

Jazz Pharmaceuticals plc (JAZZ) Wins FDA Accelerated Approval for Modeyso™ Brain Cancer Therapy

Y

Viatris, Inc. (VTRS) Achieves Key Clinical Milestones in Ophthalmology, Pain, Women’s Health

Y

Teva Pharmaceutical Industries Limited (TEVA) Gains FDA Nod for Pediatric Migraine Drug AJOVY

Y

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

Y

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA

Y

Harmony Biosciences Holdings, Inc. (HRMY) Expands WAKIX With FDA Nod for Prader-Willi

Y

Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders

Y

The student loan tax bomb hidden in Trump's new bill

Y

Prediction: This "Ten Titans" Growth Stock Will Join the $3 Trillion Club Before the End of 2027

Y

Dogecoin ETFs—and More—Could Land Soon if the SEC OKs New Rules

Y

Asahi, Red Bull, Trip to feature at Just Drinks non-alcoholic beverages conference

Y

Artifical Intelligence (AI) Is on Sale: 2 Stocks Smart Investors Are Buying Now

Y

Billionaire Ambani plans to take Reliance Jio public by mid-2026

Y

Oil Caught Between Demand Concerns and Geopolitical Risks

Y

3 Fantastic (but Overlooked) Growth Stocks to Invest $1,000 in Right Now

Y

Royalty Pharma plc (RPRX) Strikes $2B Partnership with Revolution Medicines

Y

Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035

Y

ACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome Trial

Y

PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich’s Ataxia

Y

Halozyme Therapeutics, Inc. (HALO) Hikes 2025 Guidance on ENHANZE Demand

Y

Markets Fall from Record Highs. Stock Futures Drop Ahead of Key Inflation Data.

Y

Exelixis, Inc. (EXEL) Halts Phase 3 STELLAR-305 Trial

Y

Regeneron Pharmaceuticals, Inc. (REGN) Confident on Odronextamab Approval After Setbacks

Y

Is Newsmax Stock (NMAX) a Buy?

Y

Framer secures $100m Series D funding at $2bn valuation

Y

Zeta Global At An Inflection Point: Entering Early May Lead To An Exponential Rise

S

Global Markets Mixed as Focus Shifts to Inflation Data

Y

Marvell sinks as weak data center outlook stokes custom AI chip worries

Y

3 Reasons Blue Owl Could Be A Generational Compounder

S

Germany's VDMA calls EU's exemption plans for US goods a 'slap in the face'

Y

Boeing Director Makes First Stock Purchase

Y

China’s $1.3 Trillion Stock Surge Intensifies Debate on Outlook

Y

What Stocks Are Billionaires Buying Right Now?

Y

My 3 Favorite Stocks to Buy Right Now

Y

Reddit: The Monetization Engine Is Just Getting Started

S

Heard on the Street Thursday Recap: Cook Fights Back

Y

RQI: Own The Real Estate Sector With This High-Yield CEF

S